.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05X_IVSolutionAdditives.B05XB03_Lysine.Lysine .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05X_IVSolutionAdditives.B05XB03_Lysine.Lysine| name: | Lysine |
| ATC code: | B05XB03 | route: | intravenous |
| n-compartments | 1 |
Lysine is an essential amino acid used primarily as a nutritional supplement and for the treatment of lysine deficiency states. Intravenously, lysine has been explored as a component of amino acid solutions for parenteral nutrition and as a renal radioprotector during peptide receptor radionuclide therapy (PRRT). Lysine itself is not typically used as a standalone drug but is included within certain medical or metabolic contexts. Lysine is approved for use as a nutritional supplement, but intravenous formulations for therapeutic or diagnostic use (e.g., renal protection) are typically off-label or investigational.
Estimated pharmacokinetic parameters for intravenous lysine in healthy adults based on available literature for amino acid infusion. Direct published PK models specifically for lysine with ATC B05XB03 are not available; these are general estimates extrapolated from parenteral amino acid/supplement studies.
Zhao, L, et al., & Bi, K (2012). Bioequivalence and population pharmacokinetic modeling of two forms of antibiotic, cefuroxime lysine and cefuroxime sodium, after intravenous infusion in beagle dogs. Journal of biomedicine & biotechnology 2012 507294–None. DOI:10.1155/2012/507294 PUBMED:https://pubmed.ncbi.nlm.nih.gov/22911056
Grimaldi, R, et al., & Gaita, F (2014). Laboratory aspirin resistance reversibility in diabetic patients: a pilot study using different pharmaceutical formulations. Cardiovascular drugs and therapy 28(4) 323–329. DOI:10.1007/s10557-014-6536-7 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24984883
Peer, CJ, et al., & Figg, WD (2016). UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation. Journal of clinical pharmacology 56(4) 450–460. DOI:10.1002/jcph.627 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26637161